Skip to main content
Watch Insiders

Corporate insider profile

Douglas Carr Insider Trades

Latest reported as SVP Finance & Operations of Century Therapeutics, Inc. (IPSC).

Purchase filings
0
Reported companies
1
Net open-market value
-$9,099.71
Latest transaction
Sep 14, 2026

Affiliated corporations

Reported company relationships

IPSCLatest reported

Century Therapeutics, Inc.

SVP Finance & Operations

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 14, 2026Century Therapeutics, Inc. (IPSC)SVP Finance & OperationsSale1,658$1.93$3,200
Sep 8, 2026Century Therapeutics, Inc. (IPSC)SVP Finance & OperationsSale254$2.05$520.70
Aug 3, 2026Century Therapeutics, Inc. (IPSC)SVP Finance & OperationsSale275$1.98$543.68
Jun 12, 2026Century Therapeutics, Inc. (IPSC)SVP Finance & OperationsSale1,654$2.23$3,692
Jun 8, 2026Century Therapeutics, Inc. (IPSC)SVP Finance & OperationsSale249$2.11$525.64
May 4, 2026Century Therapeutics, Inc. (IPSC)SVP Finance & OperationsSale264$2.34$618.02